GRELLI, SANDRO
 Distribuzione geografica
Continente #
NA - Nord America 25.463
EU - Europa 2.360
AS - Asia 930
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 13
OC - Oceania 7
AF - Africa 3
Totale 28.789
Nazione #
US - Stati Uniti d'America 25.444
CN - Cina 616
IT - Italia 516
UA - Ucraina 372
DE - Germania 336
IE - Irlanda 307
SE - Svezia 207
FR - Francia 145
GB - Regno Unito 132
RU - Federazione Russa 109
SG - Singapore 101
KR - Corea 88
FI - Finlandia 79
PL - Polonia 63
VN - Vietnam 36
JP - Giappone 29
BE - Belgio 21
CZ - Repubblica Ceca 21
IN - India 21
CA - Canada 18
PK - Pakistan 17
ES - Italia 12
EU - Europa 11
NL - Olanda 11
CH - Svizzera 8
AU - Australia 7
CL - Cile 7
GR - Grecia 7
BR - Brasile 5
AL - Albania 4
AT - Austria 4
HK - Hong Kong 4
TH - Thailandia 4
PH - Filippine 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
UZ - Uzbekistan 2
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
DZ - Algeria 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MX - Messico 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 28.789
Città #
Woodbridge 7.329
Wilmington 7.092
Houston 6.093
Fairfield 789
Chandler 692
Ann Arbor 530
Ashburn 359
Jacksonville 311
Seattle 304
Dublin 285
Cambridge 268
Zhengzhou 264
Rome 241
Medford 207
Dearborn 174
Beijing 135
New York 119
Lawrence 97
Boardman 66
Singapore 61
Mülheim 60
Kraków 54
Milan 44
Moscow 41
Shanghai 41
Creede 39
Hangzhou 39
Menlo Park 39
San Diego 39
Dong Ket 33
Palo Alto 30
Hefei 22
University Park 22
Brussels 21
Norwalk 21
Seoul 21
Brno 20
London 17
Toronto 17
Redwood City 16
San Mateo 16
Falls Church 14
Kunming 14
Lahore 14
Nanjing 14
Mountain View 13
Verona 13
Guangzhou 12
Saint Petersburg 12
Cedarhurst 11
Helsinki 10
Phoenix 10
Chengdu 9
Engelhard 9
Jinan 9
Kilburn 9
Takasaki 9
Auburn Hills 8
Bologna 8
Los Angeles 8
Council Bluffs 7
Fuzhou 7
Nürnberg 7
Detroit 6
Genzano di Roma 6
Hounslow 6
Madrid 6
Nanchang 6
San Francisco 6
San Jose 6
St. George 6
Hackensack 5
Indiana 5
Latina 5
Munich 5
Paris 5
Redmond 5
Ridgeland 5
Santa Clara 5
Bangkok 4
Durham 4
Groningen 4
Haikou 4
Lappeenranta 4
Manitou Springs 4
Naples 4
Nuremberg 4
Shenyang 4
Southwark 4
Tappahannock 4
Warsaw 4
Washington 4
Acton 3
Amsterdam 3
Athens 3
Baotou 3
Chicago 3
Forlì 3
Giffoni Valle Piana 3
Hanoi 3
Totale 26.459
Nome #
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 481
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression 463
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 447
Approaches towards the synthesis of 7-halo-1,2-dihydroxyindolizidines (7-halolentiginosines) thwarting Grob fragmentation processes 435
Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry 434
D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent 433
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy 428
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 428
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 424
Umbilical cord blood: the role of apoptosis in the control of CD34+ cell counts 423
Susceptibility to influenza A virus infection in mice immunosuppressed with cyclophosphamide 423
Thymic hormones and cytokines 416
Role of Bcl-2 expression for productive herpes simplex virus 2 replication 416
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 415
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro 413
Leucocyte rheological properties are altered in patients with diffuse atherosclerosis 413
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 408
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3 408
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients 404
Involvement of gD/HVEM interaction in NF-kappa B-dependent inhibition of apoptosis by HSV-1 gD 399
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 399
Involvement of HVEM receptor in activation of nuclear factor kappa B by herpes simplex virus 1 glycoprotein D 393
Immunological and endocrinological disturbances in patients after prolonged coma following head injury 393
Signaling pathway used by HSV-1 to induce NF-kappa B activation - Possible role of herpes virus entry receptor A 386
Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice 385
Herpes simplex virus 2 causes apoptotic infection in monocytoid cells 381
Efficacy of 3 '-azido 3 ' deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells 379
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 377
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction 377
(-)-(1R,2R,7S,8aR)-1,2,7-trihydroxyindolizidine ((-)-7S-OH-lentiginosine): Synthesis and proapoptotic activity 377
CD4+ lymphocyte increases in HIV patients during potent antiretroviral therapy are dependent on inhibition of CD8+ cell apoptosis 376
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 375
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 375
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 374
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 374
Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction 374
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 369
Flow cytometric method for the evaluation of the biological activity of thymic hormones 367
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 366
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 365
Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation 362
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 361
Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells 360
HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis 360
Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance 355
Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer’s disease 354
The novel proapoptotic activity of nonnatural enantiomer of Lentiginosine 353
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study 352
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 349
Immunological events during the early phase of infection with Schistosoma mansoni in mice 348
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice 347
Interaction between thymic hormones and other immunomodulatory agents 346
Effector caspase activation, in the absence of a conspicuous apoptosis induction, in mononuclear cells treated with azidothymidine 342
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy 340
Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system 339
Effects of in vivo administration of di-M-PGE2 on spleen and thymus lymphocyte subsets in mice. 338
Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice 333
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB. 332
Valutazione dell'attività citotossica in modelli animali di immuno-soppressione dopo trattamento combinato con ormoni timici/interferone ed in soggetti HIV positivi . 327
Significato e limiti dello screening sierologico nella profilassi antitetanica in ambito occupazionale. 311
Effetti di terapie combinate con timosina alfa 1, interleuchina 2 ed interferone in topi inoculati con cellule di leucemia di Friend. 305
Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases 299
Possible role of prostaglandin E2 in induction of lymphocyte apoptosis during HIV infection. Vol. 9 292
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders 292
Rationale for therapeutic approaches with thymic hormones, interleukin 2 and interferon in combination with chemotherapy. 291
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-alpha 284
Interaction between thymic hormones and other immunomodulating agents on the cell-mediated immune response. 277
NF-κB-Dependent Production of ROS and Restriction of HSV-1 Infection in U937 Monocytic Cells 264
Cell death pathologies: targeting death pathways and the immune system for cancer therapy 260
Measles immunity in an Italian teaching hospital 237
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 233
Future perspectives on drug targeting in adult T cell leukemia-lymphoma 223
Children with autism spectrum disorder and their mothers share abnormal expression of selected endogenous retroviruses families and cytokines 165
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study 164
Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards 163
Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo 162
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 150
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients 147
Cytotoxic and apoptotic effects of different extracts of Moringa oleifera Lam on lymphoid and monocytoid cells 140
The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs 129
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients 116
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview 102
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 97
Endogenous retroviruses activity as a molecular signature of neurodevelopmental disorders 93
Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients 90
Effect of microvesicles from Moringa oleifera containing miRNA on proliferation and apoptosis in tumor cell lines 87
High body mass index and night shift work are associated with COVID-19 in health care workers 82
Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings 77
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? 71
Inhibition of HECT E3 ligases as potential therapy for COVID-19 59
Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations 56
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 49
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 47
B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 47
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 46
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 44
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 42
Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients' Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs 36
Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay 33
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 30
Totale 28.763
Categoria #
all - tutte 61.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.553 642 572 535 677 597 796 728 630 726 620 475 555
2020/20214.896 516 600 474 594 559 502 625 539 122 99 163 103
2021/20221.235 67 138 65 68 29 146 74 63 115 111 50 309
2022/20231.865 159 172 61 258 160 350 157 187 136 12 142 71
2023/2024778 98 21 50 34 75 161 49 32 20 58 47 133
2024/2025106 106 0 0 0 0 0 0 0 0 0 0 0
Totale 29.240